Who Says the Art of the Letter Is Dead? | GenomeWeb

As part of its plan to promote its anti-cholesterol drug Vytorin, Merck and Schering-Plough paid 16 physicians, 14 of whom hold academic appointments, more than $450,000 for consulting and giving talks, reports the Chronicle of Higher Education. In this article, the Chronicle lists the physicians and the money they received.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.